Neoadjuvant Tislelizumab Plus Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer (NeoSPOT) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Neoadjuvant Tislelizumab Plus Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer (NeoSPOT)	Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Oral Squamous Cell Carcinoma, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, oropharynx squamous cell carcinoma, squamous cell carcinoma	Active, not recruiting	Phase 2	2025-06-06		NCT06009861

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Peking University Hospital of Stomatology	3

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Hospital of Chifeng College	Chifeng	China	1
Affiliated Hospital of Hebei University	Baoding	China	14
China Medical University School and Hospital Of Stomatology	Shenyang	China	1
First Hospital of Shanxi Medical University	Taiyuan	China	14
Peking University School and Hospital Stomatology	Beijing	China	1
Shandong Provincial Hospital	Jinan	China	24
Shanxi Cancer Hospital	Taiyuan	China	25
Tangshan People's Hospital	Tangshan	China	2
The Affiliated Hospital of Inner Mongolia Medical University	Hohhot	China	10
The Affiliated Hospital of Qingdao University	Qingdao	China	48
The First Affiliated Hospital of Harbin Medical University	Harbin	China	17
The Hospital of Stomatology of Jilin University	Changchun	China	1
Tianjin First Central Hospital	Tianjin	China	8